Jeff’s scientific expertise encompasses a broad range of therapeutic disciplines for which he serves as Team Leader or internal consultant, including leading the DH practices in Oncology and Virology. He also leads or is the internal expert on various projects in Inflammatory Diseases such as Asthma and Psoriasis. Jeff has extensive commercial and strategic perspective on the pharmaceutical and biotech industries, and often gives talks on strategic issues in oncology and personalized medicine. He has directed hundreds of in-depth licensing opportunity and valuation assessments during his tenure at DH.Before joining Defined Health, Jeff was a Senior Research Scientist and Research Project Leader in the commercial development of oligonucleotide therapeutics for viral diseases and cancer at Innovir Laboratories, and an Assistant Research Professor at The George Washington University School of Medicine. He has worked closely with two Nobel Prize recipients: Dr. Sidney Altman, on ribozymes, and Dr. Stanley Prusiner, on prions, and holds four patents in biotechnology.Jeff received a BA from University of California at San Diego, an MA in English/Creative Writing from New York University, and a PhD in Medical Microbiology from the University of California at Berkeley. He is a member of the Licensing Executives Society.